Synthesis and antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclobutane ring. Part 1: Guanosine analogues

Archiv der Pharmazie

Volumn 332, Issue 10, 1999, Pages 348-352

  Figueira, M José ^a   Blanco, J Manuel ^a   Caamaño, Olga ^a   Fernández, Franco ^a   García Mera, Xerardo ^a   López, Carmen ^a   Andrei, Graciela ^b   Snoeck, Robert ^b   Padalko, Elisabeth ^b   Neyts, Johan ^b   Balzarini, Jan ^b   De Clercq, Erik ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral testing; Carbocyclic nucleosides; Cytostatic activity; Guanosine analogues; Synthesis

Indexed keywords

3 [3' (2 AMINO 6 CHLORO 9H PURIN 9 YL) 2',2' DIMETHYLCYCLOBUTYL]PROPAN 1 OL; 3 [3' (5,7 DIAMINO 3H 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL) 2',2' DIMETHYLCYCLOBUTYL]PROPAN 1 OL; 8 AZAGUANINE; CARBOCYCLIC NUCLEOSIDE; CYCLOBUTANE; GUANINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOSTASIS; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CYCLOBUTANES; NUCLEOSIDES; TUMOR CELLS, CULTURED; VIRUSES;

EID: 0032694692     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199910)332:10<348::AID-ARDP348>3.0.CO;2-H     Document Type: Article

References (17)

1. V.E. Marquez, Adv. Antiviral Drug Des. E. De Clercq, , Ed. JAI Press Inc., Greenwich, CT, USA 1996; Vol. 2, pp. 89-146.
2. D. W. Norbeck, E. Kern, S. Hayashi, W. Rosenbrook, H. Sham, T. Herrin, J. J. Plattner, J. Erickson, J. Clement, R. Swanson, N. Shipkowitz, D. Hardy, K. Marsh, G. Arnett, W. Shannon., S. Broder, H. Mitsuya J Med. Chem. 1990, 33, 1281-1285.
3. D. F. Smee, B. B. Bamett, R. W. Sidwell, E. J. Reist, A. Holy Antivir. Res. 1995, 26, 1-9.
4. G. Yamanaka, A. V. Tuomari, M. Hagen, B. McGeever-Rubin, B. J. Terry, M. Haffey, G.S . Bisacchi, A. K. Field, Mol. Pharmacol. 1991, 40, 446-453.
5. H. R. Yang, R. L. Drain, C. A. Franco, J. M. Clark, Antivir. Res. 1996, 29, 233-241.
6. D. J. Tenney, G. Yamanaka, S. M. Voss, C. W. Cianci, A. V. Tuomari, A. K. Sheaffer, M. Alam, R. J. Colonno, Antimicrob. Agents Chemother. 1997, 41, 2680-2685.
7. L. Agrafoglio, E. Suhas, A. Farese, R. Condom, R. Challand, R. A. Earl, R. Guedj, Tetrahedron 1994, 50, 10611-10670.
8. J. E. R. Borges, F. Fernández, X. García, A. R. Hergueta, C. López, G. Andrei, R. Snoeck, M. Witvrouw, J. Balzarini, E. De Clercq, Nucleosides & Nucleotides 1998, 17, 1237-1253.
9. a) J. Balzarini, P. Herdewijin, E. De Clercq, J. Biol. Chem. 1989, 264, 6127-6133;
10. b) L. L. Bondoc Jr., W. M. Shannon, J. A. Secrist III, R. Vince, A. Friedland, Biochemistry 1990, 29, 9839-9843;
11. c) W. P. Parker, S. C. Shaddix, B. J. Bowdon, L. M. Rose, R. Vince, W. M. Shannon, L. L. Bennet Jr., Antimicrob. Agents Chemother. 1993, 37, 1004-1009.
12. a) L. B. Akella, R. Vince, Tetrahedron 1996, 52, 8407-8412;
13. b) Ref. 8.
14. J. M. Blanco, O. Caamaño, F. Fernández, G. Gómez, I. Nieto Synthesis 1996, 281-284.
15. 17N: C, H, N.
16. R. Vince, M. Hua J. Med. Chem. 1990, 33, 17-21.
17. E. De Clercq, In In vitro and ex vivo test systems to rationalize drug design and delivery, D. Crommelin, P. Couvreur, D. Duchêne Eds.; Editions de Santé, Paris, France, 1994, pp 108-125.